drugset
drugset / Trial / NCT06335316

Effect of Stellate Nerve Block in Dysphagia

NCT06335316 ↗

Completed 122 enrolled Copka Sonpashan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in China. Both groups were provided with comprehensive rehabilitation including routine rehabilitation and swallowing function training. Besides, the observation group additionally underwent the stellate ganglion block (SGB). At admission and after 20-day treatment,Yale Pharyngeal Residue Severity Rating Scale, video fluoroscopic swallowing study (VFSS), Functional Oral Intake Scale, and penetration-aspiration scale (PAS) were used to assess swallowing function.

Timeline

Start
2022-01-01
Primary completion
2023-05-04
Completion
2023-05-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 ml Other
Background Vitamin B12 Other / unclassified 500 ug Other

Indications

No indication recorded.